Mead Johnson Nutrition Co. (MJN) Given a $95.00 Price Target at Credit Suisse Group AG
Mead Johnson Nutrition Co. (NYSE:MJN) has been given a $95.00 target price by equities researchers at Credit Suisse Group AG in a report issued on Wednesday. The brokerage currently has a a “buy” rating on the stock. Credit Suisse Group AG’s target price suggests a potential upside of 18.47% from the stock’s previous close.
A number of other research analysts have also recently commented on MJN. Susquehanna reissued a “hold” rating on shares of Mead Johnson Nutrition in a research note on Sunday, July 17th. Deutsche Bank AG set a $88.00 target price on Mead Johnson Nutrition and gave the company a “hold” rating in a research note on Sunday, July 24th. Citigroup Inc. increased their target price on Mead Johnson Nutrition from $100.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, July 25th. JPMorgan Chase & Co. raised Mead Johnson Nutrition from a “neutral” rating to an “overweight” rating and set a $105.00 target price on the stock in a research note on Tuesday, July 26th. Finally, Credit Agricole SA raised Mead Johnson Nutrition from an “underperform” rating to an “outperform” rating and set a $96.00 target price on the stock in a research note on Wednesday, August 3rd. One research analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $94.33.
Shares of Mead Johnson Nutrition (NYSE:MJN) traded up 0.76% during mid-day trading on Wednesday, reaching $80.80. The company’s stock had a trading volume of 1,063,730 shares. The company’s 50-day moving average is $79.94 and its 200 day moving average is $84.66. The firm has a market cap of $14.92 billion, a price-to-earnings ratio of 30.40 and a beta of 1.26. Mead Johnson Nutrition has a 12 month low of $65.53 and a 12 month high of $94.40.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/13/mead-johnson-nutrition-co-mjn-given-a-95-00-price-target-at-credit-suisse-group-ag.html
Mead Johnson Nutrition (NYSE:MJN) last released its quarterly earnings results on Thursday, July 28th. The company reported $0.88 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.10. The firm earned $941.50 million during the quarter, compared to analyst estimates of $967.25 million. Mead Johnson Nutrition had a net margin of 13.28% and a negative return on equity of 194.30%. The business’s revenue for the quarter was down 8.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.76 EPS. On average, equities analysts anticipate that Mead Johnson Nutrition will post $3.48 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Monday, October 3rd. Stockholders of record on Monday, September 19th were issued a dividend of $0.4125 per share. The ex-dividend date was Thursday, September 15th. This represents a $1.65 dividend on an annualized basis and a dividend yield of 2.06%. Mead Johnson Nutrition’s dividend payout ratio is currently 62.03%.
In other Mead Johnson Nutrition news, Director Kimberly A. Casiano sold 710 shares of the firm’s stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $89.75, for a total value of $63,722.50. Following the completion of the sale, the director now directly owns 7,110 shares in the company, valued at $638,122.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Graciela Monteagudo sold 45,873 shares of the firm’s stock in a transaction dated Friday, August 5th. The stock was sold at an average price of $87.64, for a total transaction of $4,020,309.72. Following the completion of the sale, the senior vice president now owns 13,800 shares of the company’s stock, valued at $1,209,432. The disclosure for this sale can be found here. Insiders own 0.50% of the company’s stock.
Hedge funds have recently modified their holdings of the company. FMR LLC raised its stake in shares of Mead Johnson Nutrition by 11.8% in the second quarter. FMR LLC now owns 13,045,067 shares of the company’s stock valued at $1,183,840,000 after buying an additional 1,378,877 shares during the period. Vanguard Group Inc. raised its stake in shares of Mead Johnson Nutrition by 1.4% in the second quarter. Vanguard Group Inc. now owns 11,547,883 shares of the company’s stock valued at $1,047,971,000 after buying an additional 154,730 shares during the period. American Century Companies Inc. raised its stake in shares of Mead Johnson Nutrition by 15.2% in the second quarter. American Century Companies Inc. now owns 5,544,545 shares of the company’s stock valued at $503,167,000 after buying an additional 732,011 shares during the period. BlackRock Institutional Trust Company N.A. raised its stake in shares of Mead Johnson Nutrition by 1.1% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 5,027,781 shares of the company’s stock valued at $456,271,000 after buying an additional 56,360 shares during the period. Finally, Waddell & Reed Financial Inc. raised its stake in shares of Mead Johnson Nutrition by 47.0% in the second quarter. Waddell & Reed Financial Inc. now owns 4,274,094 shares of the company’s stock valued at $387,874,000 after buying an additional 1,367,163 shares during the period. Institutional investors and hedge funds own 96.93% of the company’s stock.
About Mead Johnson Nutrition
Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.
Receive News & Ratings for Mead Johnson Nutrition Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Co. and related companies with MarketBeat.com's FREE daily email newsletter.